Dangerous Immune & Blood Abnormalities
mRNA Boosters Trigger Abnormalities Within 48 Hours in Healthy Young Adults
A new six-month longitudinal study, published in Frontiers in Cellular and Infection Microbiology, tracked 68 healthy young adults after receiving a third dose of the Pfizer-BioNTech mRNA COVID-19 vaccine.
The findings reveal serious biological red flags emerging just 48 hours post-vaccination—including acute systemic inflammation, coagulation abnormalities, and suppression of key immune markers.
Spike in Inflammation and Clotting Markers
Within 48 hours of the third dose:
CRP (C-reactive protein) surged from 6.12 → 14.84 mg/L (p < 0.0001)
hs-CRP doubled from 1.47 → 3.52 mg/L (p < 0.0001)
D-dimers increased from 0.20 → 0.47 mg/L (p < 0.005)
These markers indicate systemic inflammation and pro-thrombotic activity in young, healthy participants (ages 20–30).
Immune Suppression After Third Dose
Lymphocyte counts dropped significantly:
2.34 → 1.91 × 10⁹/L (p < 0.0005).
Interferon-gamma (IFN-γ)—critical for antiviral defense—dropped from 54.7 → 46.1 ng/mL (p < 0.05)
These findings suggest a blunted cellular immune response and immune dysregulation following the booster.
Disruption of Coagulation Profile
Prothrombin time (PT) and aPTT were significantly prolonged, mirroring patterns seen in vaccine-induced thrombotic cases.
Even without visible symptoms, participants showed measurable coagulopathy—a warning sign in the context of myocarditis, pericarditis, and clotting syndromes.
Why This Study Matters
First to document early immune suppression and clotting activation occurring simultaneously within 48 hours of a third mRNA dose—in young, healthy adults.
Reinforces biological plausibility behind serious adverse events like myocarditis, immune dysregulation, and thrombotic complications.
Challenges the notion of “mild” reactions—showing that even in the absence of overt symptoms, mRNA boosters can trigger hidden but dangerous disruptions in inflammation, coagulation, and immune function.
 | A guest post by
|